These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 16047022)

  • 1. The synaptic Abeta hypothesis of Alzheimer disease.
    Tanzi RE
    Nat Neurosci; 2005 Aug; 8(8):977-9. PubMed ID: 16047022
    [No Abstract]   [Full Text] [Related]  

  • 2. Amyloid beta peptides and glutamatergic synaptic dysregulation.
    Parameshwaran K; Dhanasekaran M; Suppiramaniam V
    Exp Neurol; 2008 Mar; 210(1):7-13. PubMed ID: 18053990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alzheimer's disease and Abeta toxicity: from top to bottom.
    Small DH; Mok SS; Bornstein JC
    Nat Rev Neurosci; 2001 Aug; 2(8):595-8. PubMed ID: 11484003
    [No Abstract]   [Full Text] [Related]  

  • 4. epsilon-Glycation, APP and Abeta in ageing and Alzheimer disease: a hypothesis.
    Schmitt HP
    Med Hypotheses; 2006; 66(5):898-906. PubMed ID: 16442744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-fibrillar beta-amyloid abates spike-timing-dependent synaptic potentiation at excitatory synapses in layer 2/3 of the neocortex by targeting postsynaptic AMPA receptors.
    Shemer I; Holmgren C; Min R; Fülöp L; Zilberter M; Sousa KM; Farkas T; Härtig W; Penke B; Burnashev N; Tanila H; Zilberter Y; Harkany T
    Eur J Neurosci; 2006 Apr; 23(8):2035-47. PubMed ID: 16630051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intracellular amyloid-beta in Alzheimer's disease.
    LaFerla FM; Green KN; Oddo S
    Nat Rev Neurosci; 2007 Jul; 8(7):499-509. PubMed ID: 17551515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LRP in amyloid-beta production and metabolism.
    Bu G; Cam J; Zerbinatti C
    Ann N Y Acad Sci; 2006 Nov; 1086():35-53. PubMed ID: 17185504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early changes in Abeta levels in the brain of APPswe transgenic mice--implication on synaptic density, alpha7 neuronal nicotinic acetylcholine- and N-methyl-D-aspartate receptor levels.
    Unger C; Hedberg MM; Mustafiz T; Svedberg MM; Nordberg A
    Mol Cell Neurosci; 2005 Oct; 30(2):218-27. PubMed ID: 16107318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Absence of synaptophysin near cortical neurons containing oligomer Abeta in Alzheimer's disease brain.
    Ishibashi K; Tomiyama T; Nishitsuji K; Hara M; Mori H
    J Neurosci Res; 2006 Aug; 84(3):632-6. PubMed ID: 16721760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deposition of mouse amyloid beta in human APP/PS1 double and single AD model transgenic mice.
    van Groen T; Kiliaan AJ; Kadish I
    Neurobiol Dis; 2006 Sep; 23(3):653-62. PubMed ID: 16829076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amyloid beta peptide and NMDA induce ROS from NADPH oxidase and AA release from cytosolic phospholipase A2 in cortical neurons.
    Shelat PB; Chalimoniuk M; Wang JH; Strosznajder JB; Lee JC; Sun AY; Simonyi A; Sun GY
    J Neurochem; 2008 Jul; 106(1):45-55. PubMed ID: 18346200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amyloid-beta precursor protein mediates neuronal toxicity of amyloid beta through Go protein activation.
    Sola Vigo F; Kedikian G; Heredia L; Heredia F; Añel AD; Rosa AL; Lorenzo A
    Neurobiol Aging; 2009 Sep; 30(9):1379-92. PubMed ID: 18187234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autophagy, amyloidogenesis and Alzheimer disease.
    Nixon RA
    J Cell Sci; 2007 Dec; 120(Pt 23):4081-91. PubMed ID: 18032783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abeta predictor of Alzheimer disease symptoms.
    Sephton CF; Yu G
    Arch Neurol; 2008 Jul; 65(7):875-6. PubMed ID: 18625853
    [No Abstract]   [Full Text] [Related]  

  • 15. Synaptic activity regulates interstitial fluid amyloid-beta levels in vivo.
    Cirrito JR; Yamada KA; Finn MB; Sloviter RS; Bales KR; May PC; Schoepp DD; Paul SM; Mennerick S; Holtzman DM
    Neuron; 2005 Dec; 48(6):913-22. PubMed ID: 16364896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current and future therapy in Alzheimer's disease.
    van Marum RJ
    Fundam Clin Pharmacol; 2008 Jun; 22(3):265-74. PubMed ID: 18485144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cystatin C: a potential target for Alzheimer's treatment.
    Levy E
    Expert Rev Neurother; 2008 May; 8(5):687-9. PubMed ID: 18457524
    [No Abstract]   [Full Text] [Related]  

  • 18. Increased Abeta production leads to intracellular accumulation of Abeta in flotillin-1-positive endosomes.
    Rajendran L; Knobloch M; Geiger KD; Dienel S; Nitsch R; Simons K; Konietzko U
    Neurodegener Dis; 2007; 4(2-3):164-70. PubMed ID: 17596711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A highly insoluble state of Abeta similar to that of Alzheimer's disease brain is found in Arctic APP transgenic mice.
    Philipson O; Hammarström P; Nilsson KP; Portelius E; Olofsson T; Ingelsson M; Hyman BT; Blennow K; Lannfelt L; Kalimo H; Nilsson LN
    Neurobiol Aging; 2009 Sep; 30(9):1393-405. PubMed ID: 18192084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [What causes Abeta amyloidosis in the brain?].
    Matsubara E; Yanagisawa K
    No To Shinkei; 2005 Oct; 57(10):829-38. PubMed ID: 16277228
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.